DK1067911T3 - Hydrogelsammensætninger, der kan anvendes til opretholdt frigivelse af makromolekyler, samt fremgansmåder tilfremstilling deraf - Google Patents

Hydrogelsammensætninger, der kan anvendes til opretholdt frigivelse af makromolekyler, samt fremgansmåder tilfremstilling deraf

Info

Publication number
DK1067911T3
DK1067911T3 DK00904513T DK00904513T DK1067911T3 DK 1067911 T3 DK1067911 T3 DK 1067911T3 DK 00904513 T DK00904513 T DK 00904513T DK 00904513 T DK00904513 T DK 00904513T DK 1067911 T3 DK1067911 T3 DK 1067911T3
Authority
DK
Denmark
Prior art keywords
macromolecules
preparation
methods
sustained release
hydrogel compositions
Prior art date
Application number
DK00904513T
Other languages
English (en)
Inventor
Petr Kuzma
Harry Quandt
Original Assignee
Indevus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indevus Pharmaceuticals Inc filed Critical Indevus Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1067911T3 publication Critical patent/DK1067911T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymerisation Methods In General (AREA)
  • Steroid Compounds (AREA)
DK00904513T 1999-01-28 2000-01-26 Hydrogelsammensætninger, der kan anvendes til opretholdt frigivelse af makromolekyler, samt fremgansmåder tilfremstilling deraf DK1067911T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11754699P 1999-01-28 1999-01-28
PCT/US2000/001664 WO2000044356A1 (en) 1999-01-28 2000-01-26 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same

Publications (1)

Publication Number Publication Date
DK1067911T3 true DK1067911T3 (da) 2009-01-26

Family

ID=22373509

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00904513T DK1067911T3 (da) 1999-01-28 2000-01-26 Hydrogelsammensætninger, der kan anvendes til opretholdt frigivelse af makromolekyler, samt fremgansmåder tilfremstilling deraf

Country Status (11)

Country Link
US (1) US6361797B1 (da)
EP (1) EP1067911B1 (da)
JP (1) JP2002535452A (da)
AT (1) ATE407664T1 (da)
AU (1) AU757605B2 (da)
CA (1) CA2325386C (da)
DE (1) DE60040190D1 (da)
DK (1) DK1067911T3 (da)
ES (1) ES2313879T3 (da)
PT (1) PT1067911E (da)
WO (1) WO2000044356A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
DE10049297A1 (de) * 2000-10-04 2002-04-11 Basf Ag Wasserlösliche oder wasserdispergierbare (Co-)Polymerisate von Hydroxyalkyl(meth)acrylaten, Verfahren zu deren Herstellung sowie deren Verwendung als Überzugs-, Bindemittel und/oder filmbildender Hilfsstoff in pharmazeutischen Darreichungsformen
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20060015083A1 (en) * 2002-03-11 2006-01-19 Munro Hugh S Absorbent hydrogels
WO2004055057A1 (en) * 2002-12-18 2004-07-01 The University Of Melbourne Hydrogel preparation and process of manufacture thereof
US20040214914A1 (en) * 2003-04-24 2004-10-28 Ocular Sciences, Inc. Hydrogel contact lenses and package systems and production methods for same
WO2006009801A2 (en) 2004-06-17 2006-01-26 Valera Pharmaceuticals, Inc. Compositions and methods for treating central precocious puberty
US8435948B2 (en) 2004-09-29 2013-05-07 Mount Sinai School Of Medicine Of New York University Methods for inhibiting osteoclastic bone resorption and bone loss comprising administration of an anti-FSH or anti-FSHR antibody
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
EP2455072A1 (en) * 2005-03-11 2012-05-23 Endo Pharmaceuticals Solutions Inc. Controlled release formulations of octreotide
NZ543314A (en) * 2005-10-28 2007-08-31 Interag A delivery system where the driving substance contains the active component
US9120249B2 (en) * 2007-04-27 2015-09-01 Endo Pharmaceuticals Solutions Inc. Implant device release agents and methods of using same
US8222015B2 (en) * 2007-05-11 2012-07-17 Toyota Motor Engineering & Manufacturing North America, Inc. Heat resistant bioactive composition
WO2009029958A2 (en) * 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
RU2521291C2 (ru) * 2008-06-25 2014-06-27 Эндо Фармасьютикалз Солюшнз Инк. Имплантат октреотида, содержащий высвобождающее вещество
JP5622725B2 (ja) 2008-06-25 2014-11-12 エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド．Ｅｎｄｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｓｏｌｕｔｉｏｎｓｉｎｃ． エキセナチド及び他のポリペプチド類の持続的送達
EP2498763A4 (en) 2009-11-09 2015-10-07 Spotlight Technology Partners Llc HYDROGELS BASED ON POLYSACCHARIDE
JP2013509963A (ja) 2009-11-09 2013-03-21 スポットライト テクノロジー パートナーズ エルエルシー 断片化ヒドロゲル
US8329219B2 (en) * 2009-12-22 2012-12-11 Cook Biotech Incorporated Methods for producing ECM-based biomaterials
EP2872114A4 (en) * 2012-07-13 2016-04-06 Univ Tufts ENCAPSULATION OF FRAGRANCE AND / OR AROMAS IN FIBROIN BIOMATICS
CA2888472C (en) 2012-10-20 2022-06-28 Board Of Regents, The University Of Texas System Cancer cell trap
CN106163504B (zh) 2014-03-20 2021-02-09 加利福尼亚大学董事会 水凝胶毒素-吸收或结合纳米颗粒
US11661439B2 (en) 2017-12-17 2023-05-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Peptide hydrogels and use thereof
EP3791858A1 (en) * 2019-09-13 2021-03-17 UPM-Kymmene Corporation Injectable pharmaceutical formulation
EP3791864A1 (en) 2019-09-13 2021-03-17 UPM-Kymmene Corporation Method for preparing pharmaceutical composition and pharmaceutical composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298002A (en) * 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4954587A (en) 1988-07-05 1990-09-04 Ciba-Geigy Corporation Dimethylacrylamide-copolymer hydrogels with high oxygen permeability
AU618817B2 (en) * 1988-07-05 1992-01-09 Novartis Ag Dimethylacrylamide-copolymer hydrogels with high oxygen permeability
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
EP0550641B1 (en) * 1990-09-28 1994-05-25 Pfizer Inc. Dispensing device containing a hydrophobic medium
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
JPH04202201A (ja) * 1990-11-29 1992-07-23 Mitsui Toatsu Chem Inc 多孔性共重合体の製造方法
JP2530079B2 (ja) * 1992-02-05 1996-09-04 ナショナル・パテント・ディベロプメント・コーポレーション 水分膨潤性親水性製品及び薬物放出装置の製造

Also Published As

Publication number Publication date
ATE407664T1 (de) 2008-09-15
JP2002535452A (ja) 2002-10-22
EP1067911A4 (en) 2003-05-21
EP1067911B1 (en) 2008-09-10
AU757605B2 (en) 2003-02-27
AU2625600A (en) 2000-08-18
WO2000044356A1 (en) 2000-08-03
DE60040190D1 (de) 2008-10-23
US6361797B1 (en) 2002-03-26
ES2313879T3 (es) 2009-03-16
CA2325386C (en) 2010-03-23
EP1067911A1 (en) 2001-01-17
PT1067911E (pt) 2008-12-22
CA2325386A1 (en) 2000-08-03
WO2000044356A9 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
DK1067911T3 (da) Hydrogelsammensætninger, der kan anvendes til opretholdt frigivelse af makromolekyler, samt fremgansmåder tilfremstilling deraf
DE60110106D1 (de) Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ATE238771T1 (de) Herstellungsverfahren von löslichen verabreichungssystemen unter verwendung von flüchtigen salzen
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
DK1017367T3 (da) Fremgangsmåder til fremstilling af polymerbaserede frigivelsespræparater
ATE428729T1 (de) Kovalent verbrückte insulindimere
ATE475883T1 (de) Verfahren zur messung der wirkstärke von glatirameracetat
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
DE60133555D1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
DE60126483D1 (de) Gezielten modifikation der chromatinstruktur
AR047540A1 (es) Particulados
DE60034781D1 (de) In vitro verfahren zur induzierung der regulierten pankreatische-hormon produktion in nicht-pankreatischen inselngeweben, damit verbundene pharmazeutische zusammenseztzungen
DE69732407D1 (de) Verfahren fuer die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
ATE295347T1 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
GEP20074210B (en) Tropane derivatives as ccr5 modulators
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
SE9901875D0 (sv) Novel compounds
DK1812116T3 (da) Svedabsorberende kosmetisk produkt og fremgangsmåde til fremstilling heraf
ATE432063T1 (de) Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft
EA200701293A1 (ru) Терапевтическая композиция фактора роста кератиноцитов
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung